Points to be Note (Technical + Fundamental)
1. Nifty Pharma is in accumulation phase with which lead SUNPHARMA in upcoming days.
2. Positive: sales has been decreased by 6% but reserves & surplus is increased fairly.
3. On june 2,2021 Sunpharma has overtake its Subsidairy Swiss drugmaker Ferring Pharmaceuticals for producing one of the main pharma product of Swizz under Sunpharma chain. Due to this company standalone profit will be increased. NSE:SUNPHARMA
Let me know in comment what's your views?
PRO Tip: Don't sell frequently at 700 wait for a accumulation (consolidation) after forming a 2 channel of support either H.H or L.L set stoploss and wait for to hit the @715 level.